Publications
2 shownTwo Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Reductions in LDL cholesterol levels of approximately 50% were obtained with inclisiran, administered subcutaneously every 6 months. More injection-site adverse events occurred ...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 1,637
- Institution
- Wright Institute
External Links
Identifiers
- ORCID
- 0000-0002-0625-0444
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.